ロード中...
Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal
Background: L-triiodothyronine (LT3) is a substitute for levothyroxine (LT4) for thyroid cancer (TC) patients during the preparation for nuclear medicine procedures, and it is used in combination with LT4 in patients who do not respond to the standard treatment for hypothyroidism. This therapy is co...
保存先:
| 出版年: | Thyroid |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc., publishers
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6797066/ https://ncbi.nlm.nih.gov/pubmed/31364488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2019.0101 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|